Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Mar;27(3):416–420.

In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer.

K Nékám, L Kalmár, P Gergely, G Kelemen, B Fekete, I Láng, J Lévai, G Y Petrányi
PMCID: PMC1540949  PMID: 324669

Abstract

The in vitro effect of transfer factor (TF) and its obtained by gel filtration was studied on the active rosettes and leucocyte migration inhibition. TF and one fraction (IV) restored the reactivity of lymphocytes from tumour-bearing patients to tuberculin and Candida antigens in the leucocyte migration assay. TF and fraction IV was also found to enhance the number of active rosettes of tumour-bearing patients, whereas no such effect was observed on lymphocytes of patients with active SLE or controls.

Full text

PDF
416

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arala-Chaves M. P., Proença R., De Sousa M. Transfer factor therapy in a case of complex immunodeficiency. Cell Immunol. 1974 Mar 15;10(3):371–379. doi: 10.1016/0008-8749(74)90129-4. [DOI] [PubMed] [Google Scholar]
  2. Brandes L. J., Goldenberg G. J. In vitro transfer of cellular immunity against nasopharyngeal carcinoma using transfer factor from donors with Epstein-Barr virus antibody activity. Cancer Res. 1974 Nov;34(11):3095–3101. [PubMed] [Google Scholar]
  3. Chisari F. V., Edgington T. S. Human T lymphocyte "E" rosette function. I. A process modulated by intracellular cyclic AMP. J Exp Med. 1974 Oct 1;140(4):1122–1126. doi: 10.1084/jem.140.4.1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dupont B., Ballow M., Hansen J. A., Quick C., Yunis E. J., Good R. A. Effect of transfer factor therapy on mixed lymphocyte culture reactivity. Proc Natl Acad Sci U S A. 1974 Mar;71(3):867–871. doi: 10.1073/pnas.71.3.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Galant S. P., Remo R. A. Beta-adrenergic inhibition of human T lymphocyte rosettes. J Immunol. 1975 Jan;114(1 Pt 2):512–513. [PubMed] [Google Scholar]
  6. Gergely P., Vanky F., Klein E. Spontaneous and PHA-induced rosetting of human blood, tonsil lymphocytes and MLC blasts with sheep, human and horse erythrocytes. Clin Exp Immunol. 1976 Jul;25(1):23–27. [PMC free article] [PubMed] [Google Scholar]
  7. Horowitz S., Groshong T., Albrecht R., Hong R. The "active" rosette test in immunodeficiency diseases. Clin Immunol Immunopathol. 1975 Sep;4(3):405–414. doi: 10.1016/0090-1229(75)90009-4. [DOI] [PubMed] [Google Scholar]
  8. Lawrence H. S. Transfer factor. Adv Immunol. 1969;11:195–266. doi: 10.1016/s0065-2776(08)60480-0. [DOI] [PubMed] [Google Scholar]
  9. Mendes N. F., Saraiva P. J., Santos O. B. Restorative effect of normal human serum, transfer factor and thymosin on the ability of heated human lymphocytes to form rosettes with sheep erythrocytes. Cell Immunol. 1975 Jun;17(2):560–566. doi: 10.1016/s0008-8749(75)80060-8. [DOI] [PubMed] [Google Scholar]
  12. Salaman M. R. Studies on the transfer factor of delayed hypersensitivity. Effect of dialysable leucocyte extracts from people of known tuberculin sensitivity on the migration of normal guinea-pig macrophages in the presence of antigen. Immunology. 1974 Jun;26(6):1069–1080. [PMC free article] [PubMed] [Google Scholar]
  13. Sandler J. A., Smith T. K., Manganiello V. C., Kirkpatrick C. H. Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor. J Clin Invest. 1975 Nov;56(5):1271–1279. doi: 10.1172/JCI108203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sasaki M., Sekizawa T., Takahashi H., Abo T., Kumagai K. Heterogeneity of human T lymphocytes to bind sheep erythrocytes and mitogenic responses of their subpopulations. J Immunol. 1975 Dec;115(6):1509–1514. [PubMed] [Google Scholar]
  15. Soborg M., Bendixen G. Human lymphocyte migration as a parameter of hypersensitivity. Acta Med Scand. 1967 Feb;181(2):247–256. doi: 10.1111/j.0954-6820.1967.tb07255.x. [DOI] [PubMed] [Google Scholar]
  16. Valdimarsson H., Hambleton G., Henry K., McConnell I. Restoration of T-lymphocyte deficiency with dialysable leucocyte extract. Clin Exp Immunol. 1974 Feb;16(2):141–152. [PMC free article] [PubMed] [Google Scholar]
  17. Wybran J., Fudenberg H. H. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest. 1973 May;52(5):1026–1032. doi: 10.1172/JCI107267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wybran J., Levin A. S., Spitler L. E., Fudenberg H. H. Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med. 1973 Apr 5;288(14):710–713. doi: 10.1056/NEJM197304052881405. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES